- Home
- Products
MYLOTARG Gemtuzumab
MYLOTARG Gemtuzumab
- Medicine Name: MYLOTARG
- Generic Name: Gemtuzumab Ozogamicin
- Dosage Form & Strength: Single-unit vial of 5 mg
- Manufactured By: Pfizer
Mylotarg (Gemtuzumab Ozogamicin) is an FDA-approved anticancer medication used in the treatment of CD33-positive acute myeloid leukemia (AML). It is indicated for:
- Adult patients in first relapse of AML who are 60 years or older and not suitable for intensive chemotherapy.
Mylotarg is a targeted therapy that binds to CD33-expressing leukemia cells and delivers a cytotoxic agent directly to the cancer cells.
- Hepatotoxicity, including veno-occlusive disease (VOD), has been reported with Mylotarg use. Monitor liver function closely during and after treatment.
- Infusion-related reactions, including fever, chills, hypotension, and respiratory distress, may occur. Premedication and monitoring are advised.
- Myelosuppression (neutropenia, thrombocytopenia, and anemia) is common. Regular blood count monitoring is essential.
- Mylotarg may cause fetal harm when administered during pregnancy. Contraception is advised during treatment and for some time afterward.
- Breastfeeding is not recommended during treatment with Gemtuzumab.
To import Mylotarg (Gemtuzumab Ozogamicin) through GlobalRareMeds, the following documents are required:
- Valid prescription from a licensed oncologist or hematologist
- Diagnostic reports confirming the indication (e.g., CD33-positive AML)
- Government-issued ID of the patient
Order Confirmation:
Orders will be processed only upon receipt of the above documents. An import permit may be required depending on your location.
GlobalRareMeds sources Mylotarg 5 mg from certified international suppliers based in the USA, Canada, Europe, and Australia.
Our fulfillment center in Ambernath, Thane District ensures safe, secure, and regulatory-compliant delivery directly to the patient’s location after pharmacist verification.
Delivery is available across major cities in India, including Mumbai, Delhi, Chennai, Hyderabad, Ahmedabad, Bangalore, Pune, and Kolkata, and can also be facilitated internationally.
📧 Email: info@globalraremeds.com
📞 Call/WhatsApp: +91-99675 15602
Q. What is the generic name for Mylotarg?
A. The generic name is Gemtuzumab Ozogamicin.
Q. Who manufactures Mylotarg?
A. Mylotarg is manufactured by Pfizer.
Q. Is Mylotarg approved by the FDA?
A. Yes, Mylotarg was approved by the U.S. FDA in 2000.
Q. What form is Mylotarg available in?
A. Mylotarg is available as a 5 mg single-dose vial for injection.
Q. What is Mylotarg used for?
A. It is used to treat CD33-positive acute myeloid leukemia (AML) in adult patients aged 60 and above who are not candidates for standard chemotherapy.
Q. Can Mylotarg be used during pregnancy or breastfeeding?
A. No. Mylotarg may cause fetal harm. Use of effective contraception is recommended, and breastfeeding should be avoided during treatment.
Q. How can I access Mylotarg in India?
A. You can request Mylotarg through GlobalRareMeds by submitting the required documents. We ensure regulatory compliance and genuine supply.
Q. Where can Mylotarg be delivered?
A. Mylotarg can be delivered across all major Indian cities and international locations, subject to legal permissions and documentation.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
